Bilateral Acute Angle Closure in a Pediatric Patient Taking Lisdexamfetamine Dimesylate (Vyvanse).
Publication/Presentation Date
5-1-2021
Abstract
Attention-deficit/hyperactivity disorder is commonly treated with amphetamines as first line therapy. Rare case reports have shown amphetamines are associated with open angle glaucoma. We report a rare case of a 14-year-old male who presented with bilateral acute angle closure presumed to be related to his use of lisdexamfetamine dimesylate (Vyvanse). The patient's medication was discontinued which resulted in complete resolution of angle closure.
Volume
30
Issue
5
First Page
259
Last Page
259
ISSN
1536-481X
Published In/Presented At
Davanian, A. M., Fitzpatrick, J. C., Tran, D. P., Korducki, J. P., & Groth, S. L. (2021). Bilateral Acute Angle Closure in a Pediatric Patient Taking Lisdexamfetamine Dimesylate (Vyvanse). Journal of glaucoma, 30(5), e259–e261. https://doi.org/10.1097/IJG.0000000000001826
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
33675339
Department(s)
Department of Pediatrics
Document Type
Article